 |
|
Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy
Juhee Lee, Han Sang Lee, Kon Chu
encephalitis. 2022;2(1):14-18. Published online 2021 Nov 15 DOI: https://doi.org/10.47936/encephalitis.2021.00143
|
|
Citations to this article as recorded by
 Successful Treatment of Epstein-Barr Virus Reactivation-associated Transverse Myelitis Following Herpes Zoster with Intravenous Rituximab in a Cord Blood Transplant Recipient
Keijiro Sato, Rie Watanabe, Ichiro Ito, Ken-Ich Imadome, Masahiko Sumi, Hikaru Kobayashi
Internal Medicine.2024; 63(17): 2445. CrossRef Anti-CD20 Therapy in Children With Severe Epstein-Barr Virus–Associated Meningoencephalitis
Sana Ahsan, Saba Jafarpour, Mellad M. Khoshnood, Deepti Nagesh, Eugenia Ho, Nusrat Ahsan, Jonathan D. Santoro
Journal of Child Neurology.2024;[Epub] CrossRef
|